Are UK cancer cure rates worse than in most other European countries?

British Journal of General Practice

Volumn 60, Issue 571, 2010, Pages 81-82

  Souhami, Robert ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CANCER THERAPY; COLORECTAL CANCER; COMORBIDITY; EARLY DIAGNOSIS; EDITORIAL; ETHNICITY; EUROPE; GENERAL PRACTICE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; MEDICAL DECISION MAKING; PROSTATE CANCER; UNITED KINGDOM;

EARLY DETECTION OF CANCER; EUROPE; HUMANS; NEOPLASMS;

EID: 76249094857     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp10X483102     Document Type: Editorial

References (12)

1. Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract 2010; 60(571): 121-128.
2. Richards MA, Hiom S, editors. Diagnosing cancer earlier: evidence for a National Awareness and Early Diagnosis Initiative. Br J Cancer 2009; 101 (Suppl 2): S1-S129.
3. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8(9): 773-783.
4. Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 2009; 45(6): 931-991.
5. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47(4): 533-538.
6. Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003; 106(3): 416-122.
7. Coleman MP, Rachet B, Woods LM, et al. Trends in socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90(7): 1367-1373.
8. Bullard J, Coleman MP, Robinson D, et al. Completeness of cancer registration: a new method for routine use. Br J Cancer 2000; 82(5): 1111-1116.
9. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J Natl Cancer Inst 2002; 94(13): 981-990.
10. Moss S. Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005; 7(5): 230-234.
11. Autier P, Boniol M, Héry C, et al. Cancer survival statistics should be viewed with caution. Lancet Oncology 2007; 8(12): 1050-1052.
12. Doll R, Boreham J. Recent trends in cancer mortality in the UK. Brit J Cancer 2005; 92(7): 1329-1335.